(Q43774257)

English

Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial

scientific article published on 4 January 2010

Statements

Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial (English)
Michael Weichenthal
Konstanze Spieth
Norbert H Brockmeyer
Michael Tronnier
Friederike Egberts

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit